ARCHIVES

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008

After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big

December 2, 2011